BRIEF published on 09/23/2024 at 08:20, 6 months 10 days ago Tissue Regenix Group Achieves First Pre-Tax Profit Market Expansion Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
BRIEF published on 09/23/2024 at 08:20, 6 months 10 days ago Tissue Regenix Group réalise son premier bénéfice avant impôts Bénéfice Avant Impôts Expansion Du Marché Tissu Regenix Réparation Des Tissus Mous Réparation Osseuse
PRESS RELEASE published on 09/23/2024 at 08:15, 6 months 10 days ago Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit Hardman & Co Research reports on Tissue Regenix (TRX) achieving maiden pre-tax profit. TRX focuses on soft tissue and bone repair technologies, showing strong growth and profitability Hardman & Co Research Pre-tax Profit Tissue Regenix Soft Tissue Repair Bone Repair
BRIEF published on 06/25/2024 at 10:48, 9 months 8 days ago Decline of UK Life Sciences Sector Raises Concerns Investment Tissue Regenix Institutional Support UK Life Sciences Healthcare Index
BRIEF published on 06/25/2024 at 10:48, 9 months 8 days ago Le déclin du secteur britannique des sciences de la vie suscite des inquiétudes Investissement Régénix Des Tissus Sciences De La Vie Au Royaume-Uni Indice De Santé Appui Institutionnel
PRESS RELEASE published on 06/25/2024 at 10:43, 9 months 8 days ago Hardman & Co Insight: Survival of the UK life sciences sector Hardman & Co Research presents insights on the survival of the UK life sciences sector, highlighting challenges and opportunities for institutional investors. Discover more in the full report Investment Opportunities Hardman & Co Research Institutional Investors UK Life Sciences Sector Healthcare Stocks
BRIEF published on 04/10/2024 at 08:20, 11 months 23 days ago Hardman & Co Research Highlights Tissue Regenix's Impressive Growth Streak EBITDA Growth Tissue Regenix DCELL® BioRinse®
BRIEF published on 04/10/2024 at 08:20, 11 months 23 days ago Hardman & Co Research met en évidence la séquence de croissance impressionnante de Tissue Regenix Croissance BAIIA DCELL® BioRinse® Régénix Des Tissus
PRESS RELEASE published on 04/10/2024 at 08:15, 11 months 23 days ago Hardman & Co Research on Tissue Regenix (TRX): Six consecutive periods of >20% growth Hardman & Co Research highlights Tissue Regenix (TRX) with six consecutive periods of >20% growth, backed by strong commercial partners and expansion plans Hardman & Co Research Growth Investments Tissue Regenix EBITDA-positive
PRESS RELEASE published on 09/18/2023 at 11:40, 1 year 6 months ago Hardman & Co Research on Tissue Regenix (TRX): Continuing postive momentum 1H'23
Published on 04/03/2025 at 15:05, 7 hours 27 minutes ago Snowline Gold Closes Fully Subscribed C$20 Million Financing Of Flow-Through Shares
Published on 04/03/2025 at 15:00, 7 hours 32 minutes ago Kingstone Insurance Partners with Kyber Technologies Inc.
Published on 04/03/2025 at 15:00, 7 hours 32 minutes ago UniDoc Announces Debt Settlement and Renews Marketing Engagement
Published on 04/03/2025 at 15:00, 7 hours 32 minutes ago Xebra Brands’ Largest Shareholder Increases Stake as Company Explores Landmark Agricultural Agreement in Mexico
Published on 04/03/2025 at 14:30, 8 hours 2 minutes ago Dominari Holdings Highlights Supporting American Companies
Published on 04/03/2025 at 18:46, 3 hours 46 minutes ago Monthly disclosure of the total number of shares and voting rights - March 2025
Published on 04/03/2025 at 18:46, 3 hours 46 minutes ago Déclaration mensuelle des actions et droits de vote – Mars 2025
Published on 04/03/2025 at 18:00, 4 hours 32 minutes ago LDC : Chiffre d'affaires 2024-2025 : 6,3 milliards d’euros, au-delà des objectifs.
Published on 04/03/2025 at 17:45, 4 hours 47 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
